...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Question for Bear

when they say they need safety data on 1000 patients is that patients that have been dosed with RVX208 or patients recruited in this trial? Not that it will make much difference at this point because the numbers in each case will be very close.

tada

Share
New Message
Please login to post a reply